MAPT and Alzheimer disease: Instead, the Cyfip2+/− mouse model, which lacks one copy of an endogenous gene, rendering lower expression of CYFIP2 similar as that present in post-mortem AD brain23, shows stereotypical progression of phospho-tau accumulation55,69, and may therefore be a more physiological model of sporadic AD-related tau pathology.